Web Analytics

3 Latest Announced Rounds

  • $7,500,000
    Seed

    2 Investors

    Software Development
    Nov 21st, 2024
  • $6,000,000
    Series A

    1 Investors

    Transportation, Logistics, Supply Chain and Storage
    Nov 21st, 2024
  • $30,000,000
    Unknown

    1 Investors

    Financial Services
    Nov 21st, 2024
$1,631.41M Raised in 96 Funding Rounds in the past 7 Days - View All

Funding Round Profile

DalCor Pharmaceuticals

start up
Canada - Montreal, Québec
  • 22/09/2023
  • Series D
  • $80,000,000

DalCor Pharmaceuticals: DalCor Pharmaceuticals is pioneering precision medicine for patients with cardiovascular disease. By combining genetic and clinical insights, the company’s development program, dalcetrapib, is intended to reduce fatal and non-fatal myocardial infarction (MI) following a recent acute coronary syndrome and deliver superior cardiovascular outcome in a specific genetic subset of patients.


Related People